BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21239511)

  • 1. Characterization of highly efficacious allosteric agonists of the human calcium-sensing receptor.
    Ma JN; Owens M; Gustafsson M; Jensen J; Tabatabaei A; Schmelzer K; Olsson R; Burstein ES
    J Pharmacol Exp Ther; 2011 Apr; 337(1):275-84. PubMed ID: 21239511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a class of calcium sensing receptor positive allosteric modulators; 1-(benzothiazol-2-yl)-1-phenylethanols.
    Gustafsson M; Jensen J; Bertozzi SM; Currier EA; Ma JN; Burstein ES; Olsson R
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5918-21. PubMed ID: 20727747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of novel small-molecule protease-activated receptor 2 agonists.
    Gardell LR; Ma JN; Seitzberg JG; Knapp AE; Schiffer HH; Tabatabaei A; Davis CN; Owens M; Clemons B; Wong KK; Lund B; Nash NR; Gao Y; Lameh J; Schmelzer K; Olsson R; Burstein ES
    J Pharmacol Exp Ther; 2008 Dec; 327(3):799-808. PubMed ID: 18768780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients.
    Walter S; Baruch A; Dong J; Tomlinson JE; Alexander ST; Janes J; Hunter T; Yin Q; Maclean D; Bell G; Mendel DB; Johnson RM; Karim F
    J Pharmacol Exp Ther; 2013 Aug; 346(2):229-40. PubMed ID: 23674604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of clinically relevant mutations on the pharmacoregulation and signaling bias of the calcium-sensing receptor by positive and negative allosteric modulators.
    Leach K; Wen A; Cook AE; Sexton PM; Conigrave AD; Christopoulos A
    Endocrinology; 2013 Mar; 154(3):1105-16. PubMed ID: 23372019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic and clinical aspects of calcimimetics. Structure and function of calcium-sensing receptor].
    Fukumoto S
    Clin Calcium; 2008 Jan; 18(1):32-6. PubMed ID: 18175869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent updates on the calcium-sensing receptor as a drug target.
    Trivedi R; Mithal A; Chattopadhyay N
    Curr Med Chem; 2008; 15(2):178-86. PubMed ID: 18220773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathophysiology of primary hyperparathyroidism.
    Brown EM
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N24-9. PubMed ID: 12412774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic and clinical aspects of calcimimetics. Discovery and development of calcimimetics].
    Nagano N
    Clin Calcium; 2008 Jan; 18(1):37-44. PubMed ID: 18175870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of calindol derivatives as potent and selective calcium sensing receptor agonists.
    Kiefer L; Beaumard F; Gorojankina T; Faure H; Ruat M; Dodd RH
    Bioorg Med Chem; 2016 Feb; 24(4):554-69. PubMed ID: 26752095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of calcium-sensing receptor by allosteric agonists cinacalcet and AC-265347 abolishes the 1,25(OH)
    Wongdee K; Rodrat M; Keadsai C; Jantarajit W; Teerapornpuntakit J; Thongbunchoo J; Charoenphandhu N
    Arch Biochem Biophys; 2018 Nov; 657():15-22. PubMed ID: 30217510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the calcium-sensing receptor in parathyroid gland physiology.
    Chen RA; Goodman WG
    Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1005-11. PubMed ID: 15130894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular calcium-sensing receptors in fishes.
    Loretz CA
    Comp Biochem Physiol A Mol Integr Physiol; 2008 Mar; 149(3):225-45. PubMed ID: 18302989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
    Liu F; Grauer S; Kelley C; Navarra R; Graf R; Zhang G; Atkinson PJ; Popiolek M; Wantuch C; Khawaja X; Smith D; Olsen M; Kouranova E; Lai M; Pruthi F; Pulicicchio C; Day M; Gilbert A; Pausch MH; Brandon NJ; Beyer CE; Comery TA; Logue S; Rosenzweig-Lipson S; Marquis KL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):827-39. PubMed ID: 18753411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-type amino acids stimulate gastric acid secretion by activation of the calcium-sensing receptor in parietal cells.
    Busque SM; Kerstetter JE; Geibel JP; Insogna K
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G664-9. PubMed ID: 15961860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs.
    Motoyama HI; Friedman PA
    Am J Physiol Renal Physiol; 2002 Sep; 283(3):F399-406. PubMed ID: 12167589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The calcium-sensing receptor in taste tissue.
    San Gabriel A; Uneyama H; Maekawa T; Torii K
    Biochem Biophys Res Commun; 2009 Jan; 378(3):414-8. PubMed ID: 19056349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The M1 muscarinic receptor allosteric agonists AC-42 and 1-[1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one bind to a unique site distinct from the acetylcholine orthosteric site.
    Jacobson MA; Kreatsoulas C; Pascarella DM; O'Brien JA; Sur C
    Mol Pharmacol; 2010 Oct; 78(4):648-57. PubMed ID: 20660086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics.
    Cook AE; Mistry SN; Gregory KJ; Furness SG; Sexton PM; Scammells PJ; Conigrave AD; Christopoulos A; Leach K
    Br J Pharmacol; 2015 Jan; 172(1):185-200. PubMed ID: 25220431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
    Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.